본문으로 바로가기

의료진 소개

강덕희 의사

강덕희 교수

신장내과 관심의료진 등록

전문 진료 분야

만성신장병, 고혈압, 거품뇨, 혈뇨, 사구체신염, 고요산혈증, 통풍, 투석

진료 일정

학력사항

  • 의학박사, 이화여대 의과대학 의학과
  • 의학석사, 이화여대 의과대학 의학과
  • 이화여대 의과대학 의학과 졸업 (의학사)

교육 및 연구경력

  • 2018-2019  | UC Irvine 교환교수
  • 2008-현재  | 이화여대 의과대학 교수
  • 2003-2008  | 이화여대 의과대학 부교수
  • 2000-2001  | Baylor College of Medicine 수석연구강사
  • 1999-2000  | University of Washington 연구강사
  • 1997-2003  | 이화여대 의과대학 조교수
  • 1998  | 투석전문의
  • 1997  | 신장내과 분과전문의
  • 1995-1997  | 이화여대 의과대학 전임강사
  • 1993-1995  | 이화여대 부속병원 신장내과 연구강사
  • 1992-1993  | 세브란스 병원 신장내과 연구강사
  • 1992  | 내과 전문의 취득
  • 1989-1992  | 이화여대 부속병원 내과 전공의 수료

기타 학술 관련 경력

  • 2018  | Uric acid sympoisum, Boligna, Italy “Role of uric acid in progression in CKD 초청연자
  • 2017  | International Conference of Chinese Rheumatologists (ICCR) 2017, Hong Kong, “Management of Gout in CKD” 초청연자
  • 2017  | Asian Renal Association –Asian Nephrology Conference, Ningxia Yinchun, China, “ER stress as a novel therapeutic target for peritoneal fibrosis” 초청연자
  • 2016-2018  | 대한신장학회 재무이사
  • 2016  | International Congress of Renal Nutrition and Metabolism, Okinawa, Japan, “Uric Acid Paradox: Dual role as pro- and anti-oxidant” 초청연자
  • 2015  | 16th Asian Nephrology Conference, Kaosihung, Taiwan, “Asian Experience of Renal Disease Prevention: Experience in Korea” 초청연자
  • 2015  | The pre-conference of the International Congress on Renal Nutrition and Metabolism (ICRNM2016), Okinawa, Japan 초청연자
  • 2014-2016  | 대한신장학회 총무이사
  • 2013  | International Society of Hemodialysis, Kuala Lumpur, Malaysia,“Nutritional problems in Asian PD patients” 초청연자
  • 2013  | Japanese Society of Nephrology,“Peritoneal EMT by ER stress modulation”, Yokohama, Japan 초청연자
  • 2013  | World Congress of Nephrology, Hong Kong 초청연자
  • 2012-2014  | 대한신장학회 홍보이사
  • 2015  | 대한신장학회 최우수연구자상
  • 2012  | International Society of Hemodialysis, “Treatment of hyperkalemia in dialysis patients”, Taipei, Taiwan 초청연자
  • 2010  | Asian-Pacific Congress of Clinical Biochemistry,“ Role of vascular endothelium in AKI”, Hong Kong 초청연자
  • 2009  | World Congress of Nephrology, Milan, Italy, “Role of vascular disease as a culprit of progression of renal disease” 초청연자
  • 2008  | Asian Congress of Pediatric Nephrology, Bangkok, “VEGF and its receptors in chronic kidney disease” 초청연자
  • 2008  | Asian Pacific Congress of Nephrology, Kuala Lumpur, Malaysia, “Uric acid as a novel risk factor of cardiovascular disease in CKD patients” 초청연자
  • 2007  | Asian Peritoneal Dialysis College, Hong Kong, “Basic Research in PD Area” 초청연자
  • 2006  | 대한여의사회 중외연구자상
  • 2005  | World Congress of Nephrology, Singapore,“VEGF as a moderator of renal disease progression” 초청연자
  • 2005  | American Society of Nephrology, Philadelphia, USA, “Vascular injury and regeneration in chronic kidney disease : Role of angiogenesis-modulating therapy” 초청연자
  • 2004  | 2nd Japan-Korea Nephrology Forum, Tokyo, Japan, “Essential Hypertension : Is it a disease of the kidney?” 초청연자
  • 2004  | 분쉬의학상 젊은연구자상
  • 2004  | 대한신장학회 젊은 연구자상
  • 2004  | Annual Meeting of Italian Society of Nephrology, Rome, Italy, “Hyperuricemia as a risk factor of cardiovascular and renal disease” 초청연자
  • 2003  | 대한내과학회 청람연구자상
  • 2003  | World Congress of Nephrology, Berlin, Germany, “Loss and restoration of microvasculature in CRF” 초청연자
  • 2002  | Japan Nephrology Basic Science Meeting, Gifu, Japan, “Hypoxia and progression of renal disease” 초청연자
  • 2002  | Transplantation and Vascular Biology Symposium, Hannover, Germany, “Prevention of peritubular rarefaction improves renal function” 초청연자
  • 2001  | American Society of Nephrology, San Francisco, USA “Changes in renal vasculature from capillary rarefaction to obliterative arteriopathy” 초청연자
  • 2001  | 미국신장학회 ISN fellow 최우수 초록상
  • 1996  | 대한신장학회 최우수 초록상
  • 1995  | 대한신장학회 최우수 초록상

논문

  •  Association between exposure to fine particulate matter and kidney function: Results from the Korea National Health and Nutrition Examination Survey.  Environmental Research. 2022, v.212, 113080. 
  •  Early fluid management affects short-term mortality in patients with end-stage kidney disease undergoing chronic hemodialysis and requiring continuous renal replacement therapy.  BMC Nephrology. 2022, v.23 no.1, 102. 
  •  Revisiting glomerular hyperfiltration and examining the concept of high dietary protein-related nephropathy in athletes and bodybuilders.  CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION. 2022, v.31 no.1, 18-25. 
  •  Comparison of Different Types of Oral Adsorbent Therapy in Patients with Chronic Kidney Disease: A Multicenter, Randomized, Phase IV Clinical Trial.  YONSEI MEDICAL JOURNAL. 2021 , 41-49. 
  •  Fructose in the kidney: from physiology to pathology.  KIDNEY RESEARCH AND CLINICAL PRACTICE. 2021, v.40 no.4, 527-541. 
  •  Myostatin/Appendicular Skeletal Muscle Mass (ASM) Ratio, Not Myostatin, Is Associated with Low Handgrip Strength in Community-Dwelling Older Women.  INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH. 2021, v.18 no.14, 7344. 
  •  Association of Mineral Bone Disorder With Decline in Residual Kidney Function in Incident Hemodialysis Patients.  JOURNAL OF BONE AND MINERAL RESEARCH. 2020, v.35 no.2, 317-325. 
  •  Efficacy and Safety of CKD-11101 (Proposed Biosimilar of Darbepoetin-Alfa) Compared with Darbepoetin-Alfa in Patients on Hemodialysis: A Randomized, Double-Blinded, Parallel-Group Phase III Study.  BioDrugs. 2020, v.34 no.1, 99-110. 
  •  Eosinophil count and mortality risk in incident hemodialysis patients.  Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2020, v.35 no.6, 1032-1042. 
  •  Fructose metabolism as a common evolutionary pathway of survival associated with climate change, food shortage and droughts.  JOURNAL OF INTERNAL MEDICINE. 2020, v.287 no.3, 252-262. 
  •  Hyperuricemia in Kidney Disease: A Major Risk Factor for Cardiovascular Events, Vascular Calcification, and Renal Damage.  SEMINARS IN NEPHROLOGY. 2020, v.40 no.6, 574-585. 
  •  Loosening of the mesothelial barrier as an early therapeutic target to preserve peritoneal function in peritoneal dialysis.  Kidney Research and Clinical Practice. 2020, v.39 no.2, 136-144. 
  •  Physicians’ perceptions of asymptomatic hyperuricemia in patients with chronic kidney disease: A questionnaire survey.  Kidney Research and Clinical Practice. 2019, v.38 no.3, 373~381. 
  •  Tannic acid attenuates the formation of cancer stem cells by inhibiting NF-kappa B-mediated phenotype transition of breast cancer cells.  AMERICAN JOURNAL OF CANCER RESEARCH. 2019, v.9 no.8, 1664-. 
  •  The case for uric acid-lowering treatment in patients with hyperuricaemia and CKD.  Nature Reviews Nephrology. 2019, v.15 no.12, 767-775. 
  •  The interactive effects of input and output on managing fluid balance in patients with acute kidney injury requiring continuous renal replacement therapy.  Critical Care. 2019, v.23 no.1, 329. 
  •  Uric acid induced the phenotype transition of vascular endothelial cells via induction of oxidative stress and glycocalyx shedding.  FASEB JOURNAL. 2019, v.33 no.12, 13334-13345. 
  •  Paricalcitol attenuates TGF-β1-induced phenotype transition of human peritoneal mesothelial cells (HPMCs) via modulation of oxidative stress and NLRP3 inflammasome.  FASEB JOURNAL. 2019. 
  •  Fructose and sugar: A major mediator of non-alcoholic fatty liver disease.  Journal of hepatology. 2018. 
  •  THE PROTECTIVE EFFECT OF KLOTHO AGAINST CONTRAST ASSOCIATED ACUTE KIDNEY INJURY VIA THE ANTIOXIDATIVE EFFECT.  NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018. 
  •  Association of blood pressure components with mortality and cardiovascular events in prehypertensive individuals: a nationwide population-based cohort study.  Annals of medicine. 2018. 
  •  THE DISCREPANCY IN THE PREDICTABILITY OF SUBJECTIVE GLOBAL ASSESSMENT FOR MORTALITY ACCORDING TO DIALYSIS VINTAGE IN HEMODIALYSIS PATIENTS.  NEPHROLOGY DIALYSIS TRANSPLANTATION. 2018. 
  •  Factors Associated with Early Mortality in Critically Ill Patients Following the Initiation of Continuous Renal Replacement Therapy.  Journal of clinical medicine. 2018. 
  •  Hyperuricemia and progression of chronic kidney disease: role of phenotype transition of renal tubular and endothelial cells.  Contributors in Nephrology. 2018. 
  •  Gender-specific discrepancy in subjective global assessment for mortality in hemodialysis patients.  Scientific reports. 2018. 
  •  Blood pressure control during chronic kidney disease progression.  American journal of hypertension. 2017. 
  •  Metformin ameliorates the phenotype transition of peritoneal mesothelial cells and peritoneal fibrosis via a modulation of oxidative stress.  Scientific reports. 2017. 
  •  Selective tubular activation of hypoxia-inducible factor-2α has dual effects on renal fibrosis.  Scientific reports. 2017. 
  •  Screening of breast cancer stem cell inhibitors using a protein kinase inhibitor library.  Cancer Cell International. 2017. 
  •  Dementia is a risk factor for major adverse cardiac and cerebrovascular events in elderly Korean patients initiating hemodialysis: a Korean national population-based study.  BMC nephrology. 2017. 
  •  The additional benefit of weighted subjective global assessment (SGA) for the predictability of mortality in incident peritoneal dialysis patients: A prospective study.  Medicine. 2017. 
  •  Renal function affects hippocampal volume and cognition: The role of vascular burden and amyloid deposition.  Geriatrics & gerontology international. 2017. 
  •  The relationship between magnesium and endothelial function in end-stage renal disease patients on hemodialysis.  Yonsei medical journal. 2016. 
  •  Technique failure in Korean incident peritoneal dialysis patients: a national population-based study.  Kidney research and clinical practice. 2016. 
  •  FK 506 regulates pigmentation by maturing the melanosome and facilitating their transfer to keratinocytes.  Pigment cell & melanoma research. 2016. 
  •  Aging-associated renal disease in mice is fructokinase dependent.  American Journal of Physiology-Renal Physiology. 2016. 
  •  AST-120 improves microvascular endothelial dysfunction in end-stage renal disease patients receiving hemodialysis.  Yonsei medical journal. 2016. 
  •  ABO-Incompatible Kidney Transplantation.  The Ewha Medical Journal. 2015. 
  •  Effect of aldosterone on epithelial-to-mesenchymal transition of human peritoneal mesothelial cells.  Kidney research and clinical practice. 2015. 
  •  Risk of major cardiovascular events among incident dialysis patients: A Korean national population-based study.  International journal of cardiology. 2015. 
  •  Development of Metabolic Acidosis after Neobladder Reconstruction.  The Ewha Medical Journal. 2015. 
  •  Improving survival rate of Korean patients initiating dialysis.  Yonsei medical journal. 2015. 
  •  (E)-4-(3, 4-dimethoxyphenyl) but-3-en-1-ol enhances melanogenesis through increasing upstream stimulating factor-1-mediated tyrosinase expression.  PloS one. 2015. 
  •  Endoplasmic reticulum stress as a novel target to ameliorate epithelial-to-mesenchymal transition and apoptosis of human peritoneal mesothelial cells.  Laboratory Investigation. 2015. 
  •  RENOPROTECTIVE EFFECTS OF TONSIL-DERIVED MESENCHYMAL STEM CELLS IN GENTAMICIN-INDUCED ACUTE KIDNEY INJURY.  Nephrology dialysis transplantation. 2015. 
  •  Uric Acid Metabolism and the Kidney.  Chronic Renal Disease. 2015. 
  •  Baicalin and baicalein inhibit transforming growth factor-β1-mediated epithelial-mesenchymal transition in human breast epithelial cells.  Biochemical and biophysical research communications. 2015. 
  •  A COMPARISON OF STROKE INCIDENCE BETWEEN PATIENTS INITIATING HEMODIALYSIS AND PERITONEAL DIALYSIS IN KOREA.  NEPHROLOGY DIALYSIS TRANSPLANTATION. 2014. 
  •  AMP-ACTIVATED PROTEIN KINASE ACTIVATOR ATTENUATED PHENOTYPE TRANSITION AND FIBROSIS OF PERITONEAL MESOTHELIUM VIA AN AMELIORATION OF OXIDATIVE STRESS.  NEPHROLOGY DIALYSIS TRANSPLANTATION. 2014. 
  •  Uric acid induces endothelial dysfunction by vascular insulin resistance associated with the impairment of nitric oxide synthesis.  The FASEB Journal. 2014. 
  •  An assessment of survival among Korean elderly patients initiating dialysis: a national population-based study.  PloS one. 2014. 
  •  A population-based approach indicates an overall higher patient mortality with peritoneal dialysis compared to hemodialysis in Korea.  Kidney international. 2014. 
  •  Syndecan‐2 regulates melanin synthesis via protein kinase C β II‐mediated tyrosinase activation.  Pigment cell & melanoma research. 2014. 
  •  Restoring multidrug-resistance associated protein 3 attenuates cell proliferation in polycystic kidney.  American Journal of Physiology-Renal Physiology. 2014. 
  •  Renoprotective effect of red ginseng in gentamicin-induced acute kidney injury.  Laboratory Investigation. 2014. 
  •  a Comparison Of Stroke Incidence Between Patients Initiating Hemodialysis And Peritoneal Dialysis In Korea: ps1–070.  Nephrology. 2014. 
  •  Uric Acid and the Kidney.  Core Concepts in Parenchymal Kidney Disease. 2014. 
  •  Uric acid puzzle: dual role as anti-oxidantand pro-oxidant.  Electrolytes & Blood Pressure. 2014. 
  •  Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes.  Laboratory investigation. 2014. 
  •  Interleukin-1α promotes extracellular shedding of syndecan-2 via induction of matrix metalloproteinase-7 expression.  Biochemical and biophysical research communications. 2014. 
  •  Dialysis. Epidemiology, Outcome Research, Health Services 1.  Nephrology Dialysis Transplanation. 2014. 
  •  Hyperuricemia and deterioration of renal function in autosomal dominant polycystic kidney disease.  BMC nephrology. 2014. 
  •  The role of uric acid in the pathogenesis of human cardiovascular disease.  Heart. 2013. 
  •  The extracellular domain of syndecan-2 regulates the interaction of HCT116 human colon carcinoma cells with fibronectin.  Biochemical and biophysical research communications. 2013. 
  •  Effects of dexamethasone on the TGF-β1-induced epithelial-to-mesenchymal transition in human peritoneal mesothelial cells.  Laboratory investigation. 2013. 
  •  Uric acid-induced phenotypic transition of renal tubular cells as a novel mechanism of chronic kidney disease.  American Journal of Physiology-Renal Physiology. 2013. 
  •  ALTERATION OF EXTRA-AND INTRA-CELLULAR CALCIUM CONCENTRATION INDUCED ENDOTHELIAL-TO-MESENCHYMAL TRANSITION VIA AN INDUCTION OF OXIDATIVE STRESS.  NEPHROLOGY DIALYSIS TRANSPLANTATION. 2013. 
  •  GLOBOTRIAOSYLCERAMIDE (Gb3)-INDUCED ENDOTHELIAL-TO-MESENCHYMALTRANSITION (Endo-MT) AS A NOVEL MECHANISM OF RENAL DAMAGE IN FABRY DISEASE.  NEPHROLOGY DIALYSIS TRANSPLANTATION. 2013. 
  •  Far-infrared radiation acutely increases nitric oxide production by increasing Ca2+ mobilization and Ca2+/calmodulin-dependent protein kinase II-mediated phosphorylation of endothelial nitric oxide synthase at serine 1179.  Biochemical and biophysical research communications. 2013. 
  •  EFFECT OF AST-120 ON MICROVASCULAR ENDOTHELIAL DYSFUNCTION IN HEMODIALYSIS PATIENTS: A PRELIMINARY REPORT.  NEPHROLOGY DIALYSIS TRANSPLANTATION. 2013. 
  •  Novel function of the poly (c)-binding protein α-CP2 as a transcriptional activator that binds to single-stranded DNA sequences.  International journal of molecular medicine. 2013. 
  •  CLINICAL SIGNIFICANCE OF SERUM MAGNESIUM LEVEL ON ENDOTHELIAL FUNCTION IN END-STAGE RENAL DISEASE UNDERGOING HEMODIALYSIS.  NEPHROLOGY DIALYSIS TRANSPLANTATION. 2013. 
  •  Inactivation of max-interacting protein 1 induces renal cilia disassembly through reduction in levels of intraflagellar transport 20 in polycystic kidney.  Journal of Biological Chemistry. 2013. 
  •  Targeting syndecans: a promising strategy for the treatment of cancer.  Expert opinion on therapeutic targets. 2013. 
  •  EFFECTS OF KOREAN RED GINSENG ON GENTAMICIN-INDUCED ACUTE KIDNEY INJURY.  NEPHROLOGY DIALYSIS TRANSPLANTATION. 2013. 
  •  Uric acid attenuates nitric oxide production by decreasing the interaction between endothelial nitric oxide synthase and calmodulin in human umbilical vein endothelial cells: a mechanism for uric acid-induced cardiovascular disease development.  Nitric oxide. 2013. 
  •  Nephrology Dialysis Transplantation.  Nephrology Dialysis Transplantation. 2013. 
  •  A case of membranoproliferative glomerulonephritis associated with metastatic colon cancer.  The Korean journal of internal medicine. 2013. 
  •  Uric Acid-induced Phenotypic Transition of Renal 2 Tubular Cells as a Novel Mechanism of Chronic 3 Kidney Disease 4.   2013. 
  •  Hyperuricemia: A non-traditional risk factor for development and progression of chronic kidney disease?.  Kidney research and clinical practice. 2012. 
  •  Association between vascular access failure and microparticles in hemodialysis patients.  Kidney research and clinical practice. 2012. 
  •  Novel dual-binding function of a poly (C)-binding protein 3, transcriptional factor which binds the double-strand and single-stranded DNA sequence.  Gene. 2012. 
  •  Uric Acid induces hepatic steatosis by generation of mitochondrial oxidative stress potential role in fructose-dependent and-independent fatty liver.  Journal of Biological Chemistry. 2012. 
  •  Is the association between ACE genes and blood pressure mediated by postnatal growth during the first 3 years?.  Early human development. 2012. 
  •  Indoxyl sulfate-induced epithelial-to-mesenchymal transition and apoptosis of renal tubular cells as novel mechanisms of progression of renal disease.  Laboratory Investigation. 2012. 
  •  Uric acid-induced endothelial dysfunction is associated with mitochondrial alterations and decreased intracellular ATP concentrations.  Nephron Experimental Nephrology. 2012. 
  •  Pathophysiology and clinical studies in CKD 5D.  Nephrology Dialysis Transplantation Plus. 2011. 
  •  A more appropriate cardiac troponin T level that can predict outcomes in end-stage renal disease patients with acute coronary syndrome.  Yonsei medical journal. 2011. 
  •  Uric acid and chronic kidney disease: new understanding of an old problem.  Seminars in nephrology. 2011. 
  •  Uric acid: a clinically useful marker to distinguish preeclampsia from gestational hypertension.  Hypertension. 2011. 
  •  Hydration Status in Elderly Hemodialysis Patients: Bioimpedance Analysis.  Korean Journal of Nephrology. 2011. 
  •  Non-dipper status and left ventricular hypertrophy as predictors of incident chronic kidney disease.  Journal of Korean medical science. 2011. 
  •  Indoxyl sulfate–induced endothelial dysfunction in patients with chronic kidney disease via an induction of oxidative stress.  Clinical Journal of the American Society of Nephrology. 2011. 
  •  Does hyperuricemia play a causative role in the development and/or aggravation of renal, cardiovascular and metabolic disease?.  The Korean Journal of Medicine. 2011. 
  •  Potential role of uric Acid as a risk factor for cardiovascular disease.  The Korean journal of internal medicine. 2010. 
  •  Impact of low glucose degradation product bicarbonate/lactate-buffered dialysis solution on the epithelial-mesenchymal transition of peritoneum.  American journal of nephrology. 2010. 
  •  The Effect of Bradykinin on High-Glucose Induced Apoptosis in Cultured Podocytes.  Journal of the Korean Society of Hypertension. 2010. 
  •  A case report of crescentic glomerulonephritis associated with hantaan virus infection.  Nephrology Dialysis Transplantation. 2010. 
  •  Acute Renal Failure with Pulmonary Edema Induced by the Treatment of Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker in a Patient with Congenital Solitary Kidney.  The Ewha Medical Journal. 2010. 
  •  Oxidative stress with an activation of the renin–angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction.  Journal of hypertension. 2010. 
  •  Korean Red Ginseng protects the Kidney from Gentamicin-induced Injury by Modulation of Oxidative Stress.  고려인삼학회 학술대회. 2009. 
  •  Clinical implication of metabolic syndrome on chronic kidney disease depends on gender and menopausal status: results from the Korean National Health and Nutrition Examination Survey.  Nephrology Dialysis Transplantation. 2009. 
  •  Factors Affecting Production of C-reactive Protein in Vascular Smooth Muscle Cells.  Korean Journal of Nephrology. 2009. 
  •  HGF and BMP-7 ameliorate high glucose–induced epithelial-to-mesenchymal transition of peritoneal mesothelium.  Journal of the American Society of Nephrology. 2009. 
  •  The association between fetal and postnatal growth status and serum levels of uric acid in children at 3 years of age.  American journal of hypertension. 2009. 
  •  The Effect of FR167653, p38 Mitogen-Activated Protein Kinase (MAPK) Inhibitor, on the Expression of Slit Diaphragm-Associated Proteins in Experimental Diabetic Nephropathy.  Korean Journal of Nephrology. 2008. 
  •  Uric acid and cardiovascular risk.  New England Journal of Medicine. 2008. 
  •  Factors associated with endothelial dysfunction in hemodialysis patients.  Korean Journal of Nephrology. 2008. 
  •  Two Cases of Nephrolithiasis Following Administration of Cyclosporine.  Korean Journal of Nephrology. 2008. 
  •  Kwas moczowy a ryzyko sercowo-naczyniowe.  N Engl J Med. 2008. 
  •  The Effect of Monocyte Chemoattractant Protein-1 (MCP-1) on Epithelial-Mesenchymal Transition in Human Peritoneal Mesothelial Cells.  Korean Journal of Nephrology. 2008. 
  •  Treatment of Hyperuricemia in Patients with Chronic Kidney Disease.  Kidney Research and Clinical Practice. 2008. 
  •  Pre-eclampsia-a disease of oxidative stress resulting from the catabolism of DNA (primarily fetal) to uric acid by xanthine oxidase in the maternal liver: A hypothesis..  Journal of Medical Sciences. 2008. 
  •  Could uric acid have a role in acute renal failure?.  Clinical Journal of the American Society of Nephrology. 2007. 
  •  A Case of Fanconi's Syndrome due to Chinese Herb Nephropathy.  The Ewha Medical Journal. 2007. 
  •  Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease.  The American journal of clinical nutrition. 2007. 
  •  Effect of Uric Acid (UA) on C-reactive Protein (CRP) Expression in Peripheral Blood Mononuclear Cells (PBMC).  Korean Journal of Nephrology. 2007. 
  •  Analysis of erroneous overestimation of blood glucose in patients on continuous ambulatory peritoneal dialysis with icodextrin.  Korean Journal of Nephrology. 2007. 
  •  Methylenetetrahydrofolate Reductase (MTHFR) Polymorphism in Korean Chronic Renal Failure Patients: Impacts on Hyperhomocysteinemia and Peripheral Atherosclerosis.  Korean Journal of Nephrology. 2007. 
  •  Differential association of metabolic syndrome (MS) and chronic kidney disease (CKD) between men and women in Korea: Results from korean national health and nutrition examination survey (Korean NHANES).  NEPHROLOGY DIALYSIS TRANSPLANTATION. 2007. 
  •  Association of metabolic syndrome and chronic kidney disease (CKD) in Korea: Results from Korean national health and nutrition examination survey (Korean Nhanes).  NEPHROLOGY DIALYSIS TRANSPLANTATION. 2007. 
  •  Asymptomatic Hyperuricemia.  Crystal-Induced Arthropathies. 2006. 
  •  Peroxysome proliferator-activated receptor gamma (PPAR gamma) agonist inhibited angiotensin II or uric acid-induced apoptosis of human vascular endothelial cell by enhancing the activity of endothelial nitric oxide synthase.  NEPHROLOGY DIALYSIS TRANSPLANTATION. 2006. 
  •  Uric acid–a uremic toxin?.  Blood purification. 2006. 
  •  Effects of short-term partial correction of anemia in end-stage renal disease (ESRD) patients on maintenance hemodialysis: changes of amino-terminal pro B-type natriuretic peptide (NT-pro BNP) and echocardiographic parameters.  Korean Journal of Nephrology. 2006. 
  •  Markers of inflammation in the stenosis of hemodialysis vascular access.  Korean Journal of Nephrology. 2006. 
  •  Unearthing uric acid: an ancient factor with recently found significance in renal and cardiovascular disease.  Kidney international. 2006. 
  •  Hormonal and cytokine effects of uric acid.  Current opinion in nephrology and hypertension. 2006. 
  •  Uric acid and hypertension.  Current hypertension reports. 2006. 
  •  Asymptomatic Hyperuricemia.  Crystal-Induced Arthropathies: Gout, Pseudogout and Apatite-Associated Syndromes. 2006. 
  •  Effect of insulin on VEGF synthesis of peritoneal mesothelial cells: possible implications of intraperitoneal insulin on the long-term peritoneal function.  The Korean Journal of Medicine. 2006. 
  •  Serum uric acid: a risk factor and a target for treatment?.  Journal of the American Society of Nephrology. 2006. 
  •  Asymptomatic hyperuricemia.  Crystal-induced artrhopathies: gout, pseudogout and apatite-associated syndromes, Taylor and Francis Group, New York. 2006. 
  •  Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease.  Seminars in nephrology. 2005. 
  •  Combined effects of losartan and pravastatin on interstitial inflammation and fibrosis in chronic cyclosporine-induced nephropathy.  Transplantation. 2005. 
  •  Combined Effect Of Losartan And Pravastatin On Interstitial Inflammation And Fibrosis In Chronic Cyclosporine Nephropathy: W-po20015.  Nephrology. 2005. 
  •  Renoprotective effect of erythropoietin (EPO): possibly via an amelioration of renal hypoxia with stimulation of angiogenesis in the kidney.  Kidney international. 2005. 
  •  Impact Of Acid-base Status On Serum Leptin Level In Peritoneal Dialysis (pd) Patients: Correction Of Metabolic Acidosis Is Associated With A Decrease In Serum Leptin Level.  Nephrology. 2005. 
  •  Essential hypertension, progressive renal disease, and uric acid: a pathogenetic link?.  Journal of the American Society of Nephrology. 2005. 
  •  Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter.  American journal of nephrology. 2005. 
  •  Uric acid as a mediator of endothelial dysfunction, inflammation, and vascular disease.  Seminars in nephrology. 2005. 
  •  Uric Acid (ua)-induced Alteration In Proliferation And Migration Of Human Vascular Cells Are Dependent On De-novo Expression Of C-reactive Protein (crp): Fc-60070.  Nephrology. 2005. 
  •  Uric acid and preeclampsia.  Seminars in nephrology. 2005. 
  •  Calcium, magnesium, phosphate and phosphate binders, bone and mineral metabolism: Sp232 K/doqi-targets Of Mineral Metabolism In Qin Compared To Dopps.  Nephrology Dialysis Transplantation. 2005. 
  •  A Case of Graft Intolerance Syndrome Treated by Percutaneous Renal Artery Embolization.  Korean Journal of Nephrology. 2005. 
  •  Role of ERK1/2 and p38 mitogen-activated protein kinases in the regulation of thrombospondin-1 by TGF-β1 in rat proximal tubular cells and mouse fibroblasts.  Journal of the American Society of Nephrology. 2005. 
  •  Uric acid–induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells.  Journal of the American Society of Nephrology. 2005. 
  •  Basic Science Articles-Hemodynamics and Vascular Regulation-Uric Acid-Induced C-Reactive Protein Expression: Implication on Cell Proliferation and Nitric Oxide Production of Human Vascular Cells.  Journal of the American Society of Nephrology. 2005. 
  •  Factors associated with HBsAb titers in hemodialysis patients.  Nephrology Dialysis Transplantation. 2005. 
  •  Haemodialysis–vascular access 1: Sp378 Ankle-brachial Index (abi) And Vascular Access Patency In Hemodialysis Patients.  Nephrology Dialysis Transplantation. 2005. 
  •  Effects of reduced lower calcium dialysate (LCD) in hemodialysis patients.  NEPHROLOGY DIALYSIS TRANSPLANTATION. 2005. 
  •  COMBINED EFFECT OF LOSARTAN AND PRAVASTATIN ON INTERSTITIAL INFLAMMATION AND FIBROSIS IN CHRONIC CYCLOSPORINE NEPHROPATHY.  NEPHROLOGY. 2005. 
  •  Subtle renal injury is likely a common mechanism for salt-sensitive essential hypertension.  Hypertension. 2005. 
  •  Calcium, magnesium, phosphate and phosphate binders, bone and mineral metabolism: Sp216 Effects Of Reduced Lower Calcium Dialysate (lcd) In Hemodialysis Patients.  Nephrology Dialysis Transplantation. 2005. 
  •  Basic Science-Cell Biology-Role of ERK1/2 and p38 Mitogen-Activated Protein Kinases in the Regulation of Thrombospondin-1 by TGF-b1 in Rat Proximal Tubular Cells and Mouse Fibroblasts.  Journal of the American Society of Nephrology. 2005. 
  •  Hypothesis: uric acid, nephron number, and the pathogenesis of essential hypertension.  Kidney international. 2004. 
  •  Transplant graft vasculopathy: an emerging target for prevention and treatment of renal allograft dysfunction.  Yonsei medical journal. 2004. 
  •  Uric acid, endothelial dysfunction and pre-eclampsia: searching for a pathogenetic link.  Journal of hypertension. 2004. 
  •  Rapamycin inhibits platelet-derived growth factor-induced collagen, but not fibronectin, synthesis in rat mesangial cells.  Yonsei medical journal. 2004. 
  •  OR 49: Uric acid, nephron number and the pathogenesis of essential hypertension.  American Journal of Hypertension. 2004. 
  •  The impact of gender on progression of renal disease: potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection.  The American journal of pathology. 2004. 
  •  A Case of Baclofen-Associated Encephalopathy in a Maintenance Hemodialysis Patient.  Korean Journal of Nephrology. 2004. 
  •  Differential regulation of VEGF by TGF-β and hypoxia in rat proximal tubular cells.  American Journal of Physiology-Renal Physiology. 2004. 
  •  Diuretic-induced hyperuricemia does not decrease cardiovascular risk.  Journal of hypertension. 2004. 
  •  TGF-β induces proangiogenic and antiangiogenic factorsvia parallel but distinct Smad pathways.  Kidney international. 2004. 
  •  Uric acid, nephron number and the pathogenesis of essential hypertension.  American Journal of Hypertension. 2004. 
  •  Hyperhomocysteinemia (hhcy) And Endothelial Dysfunction In Hemodialysis (hd) Patients: Impact Of Nutritional Status.  Nephrology. 2003. 
  •  Vascular endothelial growth factor: a new player in the pathogenesis of renal fibrosis.  Current opinion in nephrology and hypertension. 2003. 
  •  A case of spontaneous rupture of the kidney with acute pyelonephritis.  Korean Journal of Nephrology. 2003. 
  •  The Effect of C-reactive Protein on Proliferation and VEGF Expression of Human Vascular Smooth Muscle Cells.  Korean Journal of Nephrology. 2003. 
  •  The Impact Of Gender On Progression Of Renal Disease: Potential Role Of Estrgen-mediated Vegf Regulation And Vascular Protection.  Nephrology Dialysis Transplantation. 2003. 
  •  Is There A Role For Angiogenic Growth Factors In The Treatment Of Chronic Renal Disease?.  Nephrology. 2003. 
  •  Tubulointerstitial disease: role of ischemia and microvascular disease.  Current opinion in nephrology and hypertension. 2003. 
  •  Clinical implication of hyperhomocysteinemia in hemodialysis patients: impact of nutritional status.  Korean Journal of Nephrology. 2003. 
  •  Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?.  Hypertension. 2003. 
  •  Nutritional problems of Asian peritoneal dialysis patients.  Peritoneal dialysis international. 2003. 
  •  Hyperuricemia causes glomerular hypertrophy in the rat.  American journal of nephrology. 2003. 
  •  ABI and risk factors of peripheral vascular disease in maintenance dialysis patients: According to the modality of dialysis.  Korean Journal of Nephrology. 2003. 
  •  Hyperuricemia induces endothelial dysfunction in rats.  JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2003. 
  •  Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2.  Hypertension. 2003. 
  •  A Role For Uric Acid In Promoting Vascular Inflammation.  Nephrology. 2003. 
  •  Uric acid induced C-reactive protein (CRP) expression via up-regulation of angiotensin type I receptors (AT (1)) in vascular endothelial cells and smooth muscle cells.  Journal of the American Society of Nephrology. 2003. 
  •  The regulation of inflammatory mediators by uric acid in vitro and in vivo, suggests a role for hyperuricemia in the pathogenesis of vascular disease..  JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2002. 
  •  A role for uric acid in the progression of renal disease.  Journal of the American Society of Nephrology. 2002. 
  •  Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity.  Hypertension. 2002. 
  •  A Case of severe hypokalemia induced by chronic furosemide abuse.  Korean Journal of Nephrology. 2002. 
  •  Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism.  American Journal of Physiology-Renal Physiology. 2002. 
  •  Nitric oxide modulates vascular disease in the remnant kidney model.  The American journal of pathology. 2002. 
  •  Hypothesis Paper.  environment. 2002. 
  •  Role of the microvascular endothelium in progressive renal disease.  Journal of the American Society of Nephrology. 2002. 
  •  A case of Chryseobacterium (Flavobacterium) meningosepticum peritonitis in a patient on CAPD.  Korean Journal of Nephrology. 2002. 
  •  On the mechanism of glomerular hypertrophy induced by mild hyperuricemia..  JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2002. 
  •  Angiotensin II type 1 receptor blockade ameliorates tubulointerstitial injury induced by chronic potassium deficiency.  Kidney international. 2002. 
  •  Hyperhomocysteinemia (HHcy) and endothelial dysfunction in hemodialysis (HD) patients: Impact of nutritional status..  JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2002. 
  •  Acute infection or inflammation causes a transient endothelial dysfunction in hemodialysis (HD) patients..  JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2002. 
  •  A possible link between hyperuricemia and systemic inflammatory reaction as a mechanism of endothelial dysfunction in chronic renal failure (CRF)..  JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 2002. 
  •  Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1.  Journal of the American Society of Nephrology. 2001. 
  •  Impaired angiogenesis in the aging kidney: vascular endothelial growth factor and thrombospondin-1 in renal disease.  American Journal of Kidney Diseases. 2001. 
  •  Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function.  Journal of the American Society of Nephrology. 2001. 
  •  Post-cyclosporine-mediated hypertension and nephropathy: amelioration by vascular endothelial growth factor.  American Journal of Physiology-Renal Physiology. 2001. 
  •  Pathophysiology of Renal Disease-Impaired Angiogenesis in the Remnant Kidney Model: II. Vascular Endothelial Growth Factor Administration Reduces Renal Fibrosis and Stabilizes Renal.  Journal of the American Society of Nephrology. 2001. 
  •  Pathophysiology of Renal Disease-Impaired Angiogenesis in the Remnant Kidney Model: I. Potential Role of Vascular Endothelial Growth Factor and Thrombospondin-1.  Journal of the American Society of Nephrology. 2001. 
  •  Hyperuricemia Exacerbates Chronic Cyclosporine Nephropathy1.  Transplantation. 2001. 
  •  Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism.  Hypertension. 2001. 
  •  Vascular endothelial growth factor (VEGF121) protects rats from renal infarction in thrombotic microangiopathy.  Kidney international. 2001. 
  •  Vascular endothelial growth factor accelerates renal recovery in experimental thrombotic microangiopathy.  Kidney international. 2000. 
  •  Metabolic acidosis and composite nutritional index (CNI) in CAPD patients..  Clinical nephrology. 2000. 
  •  Lupus Membranous Nephropathy with Atypical Serology.  Korean Journal of Nephrology. 1999. 
  •  Current status of peritoneal dialysis in Korea: efforts to achieve optimal outcome.  Peritoneal dialysis international. 1999. 
  •  Acid-base Balance of Korean CAPD Patients: Incidence of Metabolic Acidosis and Factors Affecting the Acid-base Status.  Korean Journal of Nephrology. 1999. 
  •  Transforming Growth Factor-beta1 (TGF-beta1) Synthesis of Human Peritoneal Mesothelial Cell.  Korean Journal of Nephrology. 1999. 
  •  High glucose solution and spent dialysate stimulate the synthesis of transforming growth factor-beta1 of human peritoneal mesothelial cells: effect of cytokine costimulation.  Peritoneal dialysis international. 1999. 
  •  Impacts of Metabolic Acidosis and Peritoneal Transport Characteristics on Plasma Levels of Acute Phase Proteins in CAPD Patients.  BLOOD PURIFICATION. 1999. 
  •  Relationship of peritoneal membrane transport characteristics to the nutritional status in CAPD patients..  Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association. 1999. 
  •  Prostaglandin synthesis of cultured human peritoneal mesothelial cells..  KIDNEY INTERNATIONAL. 1999. 
  •  Metabolic acidosis as a catabolic factor in peritoneal dialysis patients.  Peritoneal dialysis international. 1999. 
  •  Relationship between acute phase proteins and peritoneal transport characteristics in CAPD patients..  KIDNEY INTERNATIONAL. 1999. 
  •  A Case of Acute Renal Failure due to Acute Bilateral Renal Cortical Necrosis.  The Ewha Medical Journal. 1998. 
  •  Cancer Antigen 125 (CA125) as a Bulk Mass Marker of Peritoneal Mesothelial Cell in CAPD Patients.  Korean Journal of Nephrology. 1998. 
  •  Acute effects of recombinant human erythropoietin on plasma levels of proendothelin-1 and endothelin-1 in haemodialysis patients..  Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association. 1998. 
  •  Phase III Clinical Trial Evaluating Efficacy and Safety of Recombinant Human Erythropoietin (Epokine (R)) in Hemodialysis Patients.  Korean Journal of Nephrology. 1998. 
  •  Isolated abducens nerve palsy as a complication of haemorrhagic fever with renal syndrome..  Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association-European Renal Association. 1998. 
  •  Clinical Significance of Bone-Specific Alkaline Phosphatase as a Marker of Bone Turn-Over In Hemodialysis Patients: Impact of Metabolic Acidosis on Various Bone Markers.  Korean Journal of Nephrology. 1998. 
  •  A Case of Drug-Induced Acute Interstitial Nephritis Accompanying Prominent Neutrophil Infiltration.  Korean Journal of Medicine. 1998. 
  •  II Scientific Papers-ORIGINAL ARTICLES-Acute effects of recombinant human erythropoietin on plasma levels of proendothelin-1 and endothelin-1 in haemodialysis patients.  Nephrology Dialysis Transplantation. 1998. 
  •  Impact of peritoneal membrane transport characteristics on acid-base status in CAPD patients.  Peritoneal dialysis international. 1998. 
  •  Acid-Base Status of Korean CAPD Patients: Incidence of Metabolic Acidosis and Its Impact on the Nutritional Status.  Blood Purification. 1998. 
  •  Clinical significance of bone-specific alkaline phosphatase (bAP) as a marker of bone turn-over in hemodialysis (HD) patients: Impact of metabolic acidosis on these bone markers..  KIDNEY INTERNATIONAL. 1998. 
  •  Parathyroid Adenoma after Kidney Transplantation: A case report.  The Journal of the Korean Society for Transplantation. 1997. 
  •  Serum Lactate Levels in CAPD Patients with Liver Cirrhosis.  Korean Journal of Nephrology. 1997. 
  •  Systemic Necrotizing Vasculitis Presenting as Multiorgan Failure and Spontaneous Intra-abdominal Hemorrhage.  Korean Journal of Nephrology. 1997. 
  •  The Effects of Heparin on Proliferation and Endothelin Production in Glomerular Mesangial Cells.  Korean Journal of Nephrology. 1997. 
  •  Anticardiolipin Antibody (ACA) and Lupus Anticoagulant (LA): Association with Vascular Access Occlusion in Hemodialysis (HD) Patients.  Korean Journal of Medicine. 1997. 
  •  Impacts of peritoneal membrane characteristics on the acid-base status of CAPD patients..  JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 1997. 
  •  Intradialytic biologic effects of rHuEPO administration and lipid peroxidation: Changes in plasma levels of vasoactive substances during hemodialysis..  KIDNEY INTERNATIONAL. 1997. 
  •  Anticardiolipin antibody (ACA) and lupus anticoagulant (LA) in hemodialysis (HD) patients: Association with vascular access occlusion.  KIDNEY INTERNATIONAL. 1997. 
  •  Acid-base status of Korean CAPD patients: Incidence of metabolic acidosis and its impact on the nutritional status..  JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 1997. 
  •  Acute effects of recombinant human erythropoietin (rHuEPO) on plasma concentration of proendothelin-1 (proET-1) and endothelin-1 (ET-1) in hemodialysis (HD) patients..  KIDNEY INTERNATIONAL. 1997. 
  •  Plasma endothelin concentration during recombinant human erythropoietin (rHuEpo) administration in maintenance hemodialysis patients..  KIDNEY INTERNATIONAL. 1996. 
  •  Relationship between atherosclerosis and endothelin in essential hypertension..  KIDNEY INTERNATIONAL. 1996. 
  •  Changes in plasma concentration of proendothelin-1 (proET-1) and endothelin-1 (ET-1) after recombinant human erythropoietin (rHuEpo) administration in hemodialysis (HD) patients: A possible role of the activity of endothelin converting enzyme (ECE) in rHuEpo-induced hypertension..  JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 1996. 
  •  Relationships between change of serum lipid peroxide level during hemodialysis and endogenous serum antioxidants..  KIDNEY INTERNATIONAL. 1996. 
  •  Impact of nutritional status on serum lipoprotein (a) concentration in patients undergoing continuous ambulatory peritoneal dialysis..  Peritoneal dialysis international: journal of the International Society for Peritoneal Dialysis. 1996. 
  •  Comparative study of serotonin concentration in chronic renal failure (CRF) patients..  KIDNEY INTERNATIONAL. 1996. 
  •  EFFECT OF DESFERRIOXAMINE ON PLASMA ENDOTHELIN CONCENTRATION IN MAINTENANCE HEMODIALYSIS-PATIENTS.  KIDNEY INTERNATIONAL. 1995. 
  •  CHANGES IN PLASMA ENDOTHELIN CONCENTRATION AND HEMODYNAMIC PARAMETERS DURING RECOMBINANT-HUMAN-ERYTHROPOIETIN (RHUEPO) ADMINISTRATION IN MAINTENANCE HEMODIALYSIS-PATIENTS.  JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY. 1995. 
  •  Prevalence of Antibody to Hepatitis C Virus (antiHCV) with Detection of HCV-RNA by Polymerase Chain Reaction (PCR) in End Stage Renal Disease Patients on Hemodialysis.  The Ewha Medical Journal. 1994. 
  •  The effect of dilazep (cormelian) on proteinuria and renal function in patients with primary glomerulonephritis.  Korean Journal of Nephrology. 1993. 
  •  Antihypertensive effect of perindopril in patients with essential hypertension.  Korean Journal of Nephrology. 1993. 
  •  Fungal peritonitis in patients with continuous ambulatory peritoneal dialysis.  Korean Journal of Nephrology. 1993. 
  •  Comparative study of hepatitis C virus antibody between hemodialysis and continuous ambulatory peritoneal dialysis patients.  Yonsei medical journal. 1993.